Yohann Loriot, Arlene O. Siefker-Radtke, Terence W. Friedlander, Andrea Necchi, Alexander Z. Wei, Srikala S. Sridhar, Benjamin Garmezy, Santiago Arroyo, Emma Gartside, Jie Liu, Carly Campbell, Justin Bader, Daniel P. Petrylak. "A phase 2/3 study of bicycle toxin conjugate zelenectide pevedotin (BT8009) targeting nectin-4 in patients with locally advanced or metastatic urothelial cancer (la/mUC; Duravelo-2).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps4619